Evoked potentials in multiple sclerosis before and after high-dose methylprednisolone infusion

Area of Science:

• Neuroscience
• Clinical Neurology

Background:

• Multiple sclerosis (MS) and acute optic neuritis (AON) are inflammatory demyelinating conditions.
• High-dose corticosteroid therapy, particularly methylprednisolone, is a standard treatment for these conditions.
• The precise electrophysiological effects of this therapy on neural pathways remain an area of investigation.

Purpose of the Study:

• To evaluate the impact of high-dose methylprednisolone infusions on electrophysiological measures in patients with MS and AON.
• To correlate clinical outcomes with changes in evoked potentials following treatment.

Main Methods:

• Study included 8 patients with definite multiple sclerosis and 2 patients with acute optic neuritis.
• Patients received intravenous methylprednisolone (1 g daily for 3 days).
• Visual, brainstem auditory, and somatosensory evoked potentials were recorded before and after treatment.

Main Results:

• No significant changes were observed in the parameters of visual, brainstem auditory, or somatosensory evoked potentials.
• These electrophysiological findings were noted despite observed clinical improvements in some patients.

Conclusions:

• High-dose methylprednisolone therapy for MS and AON may not produce measurable changes in central nervous system conduction as assessed by evoked potentials.
• Further research is needed to understand the relationship between clinical response and electrophysiological markers in these conditions.